| Abstrakt: |
Objective: Lower extremity edema (LEE) can arise from various conditions such as venous insufficiency, lymphedema, and systemic diseases, making its diagnosis challenging. Lymphoscintigraphy has become an essential tool in accurately diagnosing lymphedema by visualizing lymphatic function and identifying abnormalities. Materials and Methods: In this retrospective study, we evaluated 66 patients with suspected lymphedema who underwent lymphoscintigraphy between January 2023 and April 2024. Patient demographic data, including age, gender, and body mass index (BMI), were collected, and the lymphoscintigraphy results were reviewed to assess lymphatic dysfunction. Lymphoscintigraphy findings were classified using the Lee Bergan and Chang classification systems, and statistical comparisons were made between patients with and without lymphedema. Results: Of the 66 patients, 55 were diagnosed with lymphedema, with a higher prevalence in females (80%). Lymphedema was bilateral in 40% of the cases. No significant differences were found in age, gender, or BMI between patients with and without lymphedema. Lymphoscintigraphy detected inguinal lymph node pathology in 55 (83%), popliteal lymph node pathology in 49 (74%), main lymphatic duct pathology in 54 (82%), collateral duct pathology in 49 (74%), and dermal-backflow pathology in 48 (73%) of the patients. Most patients were classified as moderate-stage (G2, P2) lymphedema. Conclusion: In conclusion, lymphoscintigraphy demonstrated high diagnostic efficacy, confirming lymphedema in the majority of cases. It not only facilitated early diagnosis but also provided valuable insights into disease staging, enabling more targeted interventions. This study supports the role of lymphoscintigraphy as a critical tool in the management of lymphedema, offering comprehensive information that aids in both diagnosis and treatment planning. [ABSTRACT FROM AUTHOR] |
